Conestoga Capital Advisors’s Integra LifeSciences IART Stock Holding History

Conestoga Capital Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$335K	–	140
2021 Q4	$335K	Hold	5,000	–	–	﹤0.01%	131
2021 Q3	$342K	Hold	5,000	–	–	﹤0.01%	132
2021 Q2	$341K	Hold	5,000	–	–	﹤0.01%	128
2021 Q1	$345K	Hold	5,000	–	–	0.01%	123
2020 Q4	$325K	Hold	5,000	–	–	0.01%	131
2020 Q3	$236K	Hold	5,000	–	–	﹤0.01%	139
2020 Q2	$235K	Hold	5,000	–	–	0.01%	143
2020 Q1	$223K	Hold	5,000	–	–	0.01%	137
2019 Q4	$291K	Hold	5,000	–	–	0.01%	136
2019 Q3	$300K	Hold	5,000	–	–	0.01%	124
2019 Q2	$279K	Hold	5,000	–	–	0.01%	131
2019 Q1	$279K	Hold	5,000	–	–	0.01%	128
2018 Q4	$225K	Hold	5,000	–	–	0.01%	120
2018 Q3	$329K	Hold	5,000	–	–	0.01%	108
2018 Q2	$322K	Hold	5,000	–	–	0.01%	108
2018 Q1	$277K	Hold	5,000	–	–	0.01%	112
2017 Q4	$239K	Hold	5,000	–	–	0.01%	115
2017 Q3	$252K	Hold	5,000	–	–	0.01%	107
2017 Q2	$273K	Hold	5,000	–	–	0.01%	104
2017 Q1	$211K	Sell	5,000 -3,000	-38%	-$128K	0.01%	110
2016 Q4	$343K	Hold	8,000	–	–	0.02%	91
2016 Q3	$330K	Hold	8,000	–	–	0.02%	90
2016 Q2	$319K	Hold	8,000	–	–	0.02%	91
2016 Q1	$269K	Hold	8,000	–	–	0.02%	93
2015 Q4	$271K	Hold	8,000	–	–	0.02%	92
2015 Q3	$238K	Sell	8,000 -1,786	-18%	-$55.8K	0.02%	100
2015 Q2	$269K	Hold	9,786	–	–	0.02%	97
2015 Q1	$247K	Hold	9,786	–	–	0.02%	103
2014 Q4	$217K	Buy	+9,786	New	+$198K	0.02%	112

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Conestoga Capital Advisors's IART Position: Q1 2022 in Review

Conestoga Capital Advisors sold out of Integra LifeSciences (IART) in Q1 2022, closing a stake of 5,000 shares — an estimated $335K sold.

Conestoga Capital Advisors first reported a position in IART in Q4 2014 and held it in 29 quarters. The position peaked at $345K in Q1 2021. 278 funds tracked by Wall St. Rank hold IART as of Q1 2022.

Conestoga Capital Advisors reported no remaining Integra LifeSciences position as of Q1 2022 after selling out during the quarter.
Conestoga Capital Advisors sold 5,000 Integra LifeSciences shares in Q1 2022, an estimated $335K.
Conestoga Capital Advisors first reported a position in Integra LifeSciences in Q4 2014 and held it in 29 quarters.
Conestoga Capital Advisors's Integra LifeSciences position peaked at $345K in Q1 2021.
278 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2022.

Based on Conestoga Capital Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.